• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ProMIS Neurosciences Inc. - Common Shares (NQ:PMN)

    11.29 +0.56 (+5.22%)
    Streaming Delayed Price Updated: 12:22 PM EDT, Apr 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about ProMIS Neurosciences Inc. - Common Shares

    < Previous 1 2 3 4 5 Next >
    News headline image
    ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    Which stocks are moving before the opening bell on Friday? ↗
    Via Chartmill
    News headline image
    ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill
    News headline image
    Top movers in Monday's session ↗
    Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
    Via Chartmill
    News headline image
    The market is filled with gapping stocks in Monday's session. ↗
    In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down. 
    Via Chartmill
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session. 
    Via Chartmill
    News headline image
    ProMIS Neurosciences Announces Reverse Stock Split
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank? ↗
    Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
    Via Benzinga
    News headline image
    ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    What's going on in today's pre-market session ↗
    Discover the top movers in Monday's pre-market session and stay informed about market dynamics. 
    Via Chartmill
    News headline image
    ProMIS Neurosciences Announces Private Placement Financing
    $3 million private financing plus an additional $9 million of proceeds due to exercise of warrants, for gross proceeds of approximately $12.0 million 
    From ProMIS Neurosciences Inc.
    Via GlobeNewswire
    News headline image
    Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket ↗
    Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results. 
    Via Benzinga
    News headline image
    Which stocks are experiencing notable movement on Tuesday? ↗
    Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    News headline image
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session. 
    Via Chartmill
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.